HOME  >  Pipelines

GM101

GM101

Indication : Solid Tumor

Development stage : Preparing phase II clinical trial

GM oncolytic virus harboring state-of-the-art genetic modifications to maximize cancer-specific viral replication and killing effect





Phase I completion: GM101 demonstrated good safety profile and therapeutic efficacy by intratumoral administration
TOP